Breakthrough T1D (formerly JDRF) Statement for the Record to the U.S. Senate Committee on Appropriations for the “Biomedical Research: Keeping America’s Edge in Innovation” hearing on April 30, 2025
Breakthrough T1D, formerly JDRF, is the leading global type 1 diabetes (T1D) research and advocacy organization. Breakthrough T1D helps make…
Type 1 diabetes vs. type 2 diabetes
Though they share some similarities, type 1 diabetes (T1D) and type 2 diabetes (T2D) have different causes, effects, and treatments.
Adam Singer: An innovative volunteer and fundraising leader
The Breakthrough T1D Real Estate Games is sponsored by the commercial real estate community to benefit type 1 diabetes research.
Pat McFeeley: Thinking big for cures
For Pat McFeeley, Breakthrough T1D Ride is a great example of bringing people together to make a difference for people…
Cell therapies in clinical trials: Moving the needle forward
Breakthrough T1D believes that novel cell therapies in the clinical pipeline will transform T1D management, and Project ACT is how…
Could drugs like Ozempic also benefit people with type 1 diabetes?
Learn more about GLP-1 therapies and SGLT inhibitors, and how drugs like Ozempic may one day be able to help…
Riding coast to coast for cures
Matt Varey, a key volunteer with Breakthrough T1D, will embark on a two-month-long, 7,500 km cycling journey across Canada to…
From unexpected diagnosis to DIAGNODE-3 participant
Katie Howell was diagnosed with type 1 diabetes last year at age 25. Now, she's the first DIAGNODE-3 trial participant…
Gearing up for the Breakthrough T1D Ride 2025 season
We’re gearing up for an incredible Breakthrough T1D Ride 2025 season. Check out this year's beautiful destinations and ride with…
ATTD 2025: Closing the loop to cures
At ATTD 2025, Breakthrough T1D led sessions showcasing advancements in T1D cell therapies, early detection, and technology to improve lives.
